are combination approaches the way forward for treating patients with triple-negative breast cancer?
Published 2 years ago • 63 plays • Length 1:04Download video MP4
Download video MP3
Similar videos
-
1:14
the importance of a biomarker-directed approach in triple-negative breast cancer
-
1:03
new directions in immunotherapy for improving outcomes in tnbc
-
1:58
promising novel approaches to the treatment of tnbc
-
1:30
emerging immunotherapy beyond checkpoint inhibitors for tnbc
-
1:07
precision medicine for metastatic triple-negative breast cancer
-
2:05
treatment advances in tnbc
-
1:04
future directions in triple-negative breast cancer research
-
0:41
recent advances in targeted therapies for tnbc
-
0:53
keynote-522 demonstrates potential for immunotherapy in triple-negative breast cancer
-
1:34
strategies to improve the response to immunotherapy in tnbc
-
1:24
combining chemotherapy, cd40 agonist, and flt3 ligand in triple-negative breast cancer
-
2:30
highlighting a subset of tnbc for targeted therapy
-
4:40
case 3: the use of combination therapy in triple-negative breast cancer
-
1:10
comparing 3 types of targeted therapies for triple-negative breast cancer
-
1:15
clinical implications of progress in tnbc therapies
-
1:22
immunological signatures to predict outcomes in patients with tnbc
-
1:51
optimal chemotherapy combinations in tnbc gbrca subtypes
-
2:38
nivolumab and ipilimumab with tumour-infiltrating lymphocytes to treat triple-negative breast ca...
-
4:48
ar triple negative breast cancer clinical trial